Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2000504	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-04-28	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-04	view
JYHB2000116	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-03-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-22	view
JYHB1701643	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2018-01-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2018-01-14	view
JYHB2000118	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-02-13	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-22	view
JYHB2000037	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-02-07	view
JYHB2000115	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-03-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-22	view
JYHB1701642	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2018-01-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2018-01-14	view
JYHB2000034	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-02-07	view
JYHB2000503	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-04-28	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-04	view
JYHB2000036	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-02-07	view
JYHB2000507	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-04-24	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-04	view
JYHB2000114	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-03-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-22	view
JYHB2000033	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-02-07	view
JYHB2000506	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-04-28	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-04	view
JYHB2000035	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-02-07	view
JYHB1701641	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2018-01-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2018-01-14	view
JYHB2000508	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-04-24	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-04	view
JYHB2000038	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-01-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-02-07	view
JYHB2000505	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-04-28	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-04	view
JYHB2000113	马来酸阿法替尼片	Afatinib Dimaleate	Tablet	Chemical Drugs	Supplementary Application	2020-03-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2020-06-22	view